Evaluation of the therapeutic potential of the epidermal growth factor receptor tyrosine kinase inhibitor gefitinib in preclinical models of bladder cancer

  1. Lookup NU author(s)
  2. Jose Dominguez-Escrig
  3. John Kelly
  4. Professor David Neal
  5. Dr Sonya King
  6. Dr Barry Davies
Author(s)Dominguez-Escrig JL, Kelly JD, Neal DE, King SM, Davies BR
Publication type Article
JournalClinical Cancer Research
Year2004
Volume10
Issue14
Pages4874-4884
ISSN (print)1078-0432
ISSN (electronic)1557-3265
Full text for this publication is not currently held within this repository. Alternative links are provided below where available.
PublisherAmerican Association for Cancer Research
URLhttp://dx.doi.org/10.1158/1078-0432.CCR-04-0034
DOI10.1158/1078-0432.CCR-04-0034
PubMed id15269164
Actions    Link to this publication